Literature DB >> 21791444

Enterococci increase the morbidity and mortality associated with severe intra-abdominal infections in elderly patients hospitalized in the intensive care unit.

Hervé Dupont1, Arnaud Friggeri, Jérémy Touzeau, Norair Airapetian, François Tinturier, Eric Lobjoie, Emmanuel Lorne, Moustafa Hijazi, Jean-Marc Régimbeau, Yazine Mahjoub.   

Abstract

OBJECTIVES: Enterococci may increase morbidity and mortality in elderly patients with intra-abdominal infections (IAIs) hospitalized in the intensive care unit (ICU). PATIENTS AND METHODS: A single-centre, retrospective evaluation of an ICU database (1997-2007) of elderly ICU patients (≥75 years) with a severe IAI was performed. Demographics, severity scores, underlying diseases, microbiology and outcomes were recorded. Patients with enterococci isolated in peritoneal fluid (E+ group) were compared with those lacking enterococci in peritoneal fluid (E- group). Stepwise multivariate logistic regression was used to identify independent factors associated with mortality.
RESULTS: One hundred and sixty patients were included (mean ± SD age 82 ± 5 years; n = 72 in the E+ group). The E+ group was more severely ill than the E- group, with higher Simplified Acute Physiologic Score 2 (61 ± 20 versus 48 ± 16, P = 0.0001) and Sequential Organ Failure Assessment scores (8 ± 3 versus 5 ± 3, P = 0.0001), a greater postoperative infection rate (58.3% versus 34.1%, P = 0.01), a higher incidence of inappropriate empirical antimicrobial therapies (33.3% versus 19.3%, P = 0.04), a longer duration of mechanical ventilation (11.8 ± 10.9 versus 7.8 ± 10.2 days, P = 0.02) and greater vasopressor use (7.2 ± 7.1 versus 3.3 ± 4.1 days, P = 0.001). ICU mortality was higher in the E+ group than in the E- group (54.2% versus 38.6%, P = 0.05). In the multivariate analysis, E+ status was independently associated with mortality (odds ratio 2.24; 95% confidence interval 1.06-4.75; P = 0.03).
CONCLUSIONS: In severely ill, elderly patients in the ICU for an IAI, the isolation of enterococci was associated with increased disease severity and morbidity and was an independent risk factor for mortality.

Entities:  

Mesh:

Year:  2011        PMID: 21791444     DOI: 10.1093/jac/dkr308

Source DB:  PubMed          Journal:  J Antimicrob Chemother        ISSN: 0305-7453            Impact factor:   5.790


  22 in total

Review 1.  Antimicrobial Lessons From a Large Observational Cohort on Intra-abdominal Infections in Intensive Care Units.

Authors:  Dirk Vogelaers; Stijn Blot; Andries Van den Berge; Philippe Montravers
Journal:  Drugs       Date:  2021-05-26       Impact factor: 9.546

Review 2.  Antibacterial Prophylaxis for Surgical Site Infection in the Elderly: Practical Application.

Authors:  Maria Adriana Cataldo; Guido Granata; Nicola Petrosillo
Journal:  Drugs Aging       Date:  2017-07       Impact factor: 3.923

3.  Antibiotic duration can be shortened in postoperative intra-abdominal infection.

Authors:  Im-Kyung Kim; Jae Gil Lee
Journal:  J Thorac Dis       Date:  2018-09       Impact factor: 2.895

4.  Trial of short-course antimicrobial therapy for intraabdominal infection.

Authors:  Robert G Sawyer; Jeffrey A Claridge; Avery B Nathens; Ori D Rotstein; Therese M Duane; Heather L Evans; Charles H Cook; Patrick J O'Neill; John E Mazuski; Reza Askari; Mark A Wilson; Lena M Napolitano; Nicholas Namias; Preston R Miller; E Patchen Dellinger; Christopher M Watson; Raul Coimbra; Daniel L Dent; Stephen F Lowry; Christine S Cocanour; Michaela A West; Kaysie L Banton; William G Cheadle; Pamela A Lipsett; Christopher A Guidry; Kimberley Popovsky
Journal:  N Engl J Med       Date:  2015-05-21       Impact factor: 91.245

5.  Short-Course Antimicrobial Therapy for Intraabdominal Infection.

Authors:  Christopher A Guidry; Robert G Sawyer
Journal:  N Engl J Med       Date:  2015-10-15       Impact factor: 91.245

6.  Pyrosequencing reveals the complex polymicrobial nature of invasive pyogenic infections: microbial constituents of empyema, liver abscess, and intracerebral abscess.

Authors:  C D Sibley; D L Church; M G Surette; S E Dowd; M D Parkins
Journal:  Eur J Clin Microbiol Infect Dis       Date:  2012-04-28       Impact factor: 3.267

7.  Factors Influencing the Prognosis of Patients with Intra-Abdominal Infection and Its Value in Assessing Prognosis.

Authors:  Jianfei Pan; Quanwei Zhu; Xiao Wu; Xiaoqian Zhang; Jun Xu; Linlin Pan; Xiang Mao
Journal:  Infect Drug Resist       Date:  2021-08-24       Impact factor: 4.003

8.  Short-course antibiotic therapy for critically ill patients treated for postoperative intra-abdominal infection: the DURAPOP randomised clinical trial.

Authors:  Philippe Montravers; Florence Tubach; Thomas Lescot; Benoit Veber; Marina Esposito-Farèse; Philippe Seguin; Catherine Paugam; Alain Lepape; Claude Meistelman; Joel Cousson; Antoine Tesniere; Gaetan Plantefeve; Gilles Blasco; Karim Asehnoune; Samir Jaber; Sigismond Lasocki; Herve Dupont
Journal:  Intensive Care Med       Date:  2018-02-26       Impact factor: 17.440

9.  Evaluation of a polymerase chain reaction assay for pathogen detection in septic patients under routine condition: an observational study.

Authors:  Frank Bloos; Svea Sachse; Andreas Kortgen; Mathias W Pletz; Marc Lehmann; Eberhard Straube; Niels C Riedemann; Konrad Reinhart; Michael Bauer
Journal:  PLoS One       Date:  2012-09-27       Impact factor: 3.240

10.  Essentials for selecting antimicrobial therapy for intra-abdominal infections.

Authors:  Stijn Blot; Jan J De Waele; Dirk Vogelaers
Journal:  Drugs       Date:  2012-04-16       Impact factor: 9.546

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.